Bruce Linton

Bruce Linton Recent News

MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
Bruce Linton, Chairman of Gage Cannabis: 'New York One of the Biggest Movers' And Will Soon Prove It
Gage Growth Posts Q4 Earnings: What Cannabis Stock Investors Need To Know
What Will The Psychedelics Space Look Like In 2021? Experts Weigh In
Bruce Linton On His $150M Venture: 'Hemp's Disruptive Potential Is Higher Than CBD'
Gage Cannabis Seeks $50M In Financing Before IPO, Exec Chair Bruce Linton Says
Vireo's Revenue Spikes 34% In Cannabis Company's 'Strongest Quarter Of Growth'
Cannabis Vet Bruce Linton Out At Vireo
Red Light Holland Lists On CSE, Appoints Bruce Linton As Advisory Chair
Omura Chief Praises Funding Efforts, Has High Hopes For Rest Of 2020
Bruce Linton Joins $5M Funding Round For CBD Startup Omura
Vireo Health Raises $10M In Private Offering, Says It's Made Cost Cuts
The Psychedelics Bull Run Has Begun With Publicly-Traded MindMed
MindMed Lists On NEO Exchange, Becomes First Psychedelics Company To Go Public
The Council For Federal Cannabis Regulation Launches, Targets CBD Regulation First
Bruce Linton's 2020 Vision: Free CBD, Cannabis Opportunities In Europe, Legal Psychedelics
Cannabis Execs Tackle Branding, Pot Stock Valuations: 'Dispensaries Are The Brand'
Martha Stewart Will Launch CBD Products For Animals: Here's What You Need To Know
Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: 'The Therapeutic Potential Of Psychedelics Is Greater Than Cannabinoids'
The Keys To Understanding Psilocybin's Medical Value, Market Potential
Vireo Health Trades Down On Q3 Results, CEO Sees 'Clear Path To Profitability'
Exclusive: Canopy Growth's CEO On The Cannabis Company's Stock Price, Growth Potential, Global Footprint